Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer
Nilantha Bandara, Tamila J. Stott Reynolds, Rebecca Schehr, Rajendra P. Bandari, Philipp J. Diebolder, Stephanie Krieger, Jingli Xu, Yubin Miao, Buck E. Rogers, Charles J. Smith
Dive into the research topics of 'Matched-pair, 86Y/90Y-labeled, bivalent RGD/bombesin antagonist, [RGD-Glu-[DO3A]-6-Ahx-RM2], as a potential theranostic agent for prostate cancer'. Together they form a unique fingerprint.